Animal models in obesity and hypertension

Current Hypertension Reports

Volumn 15, Issue 3, 2013, Pages 190-195

  Segal Lieberman, Gabriella ^a   Rosenthal, Talma ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aldosterone; Animal models; Hypertension; Leptin; Melanocortin system; Obesity; Renin angiotensin system; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN RECEPTOR; LEPTIN; MELANOCORTIN; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR;

ADRENERGIC SYSTEM; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN VASCULAR RESISTANCE; DISEASE MODEL; DISEASE SEVERITY; ENERGY BALANCE; ENERGY EXPENDITURE; HEART RATE VARIABILITY; HORMONE RELEASE; HUMAN; HYPERTENSION; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; LEPTIN; OBESITY; RENIN-ANGIOTENSIN SYSTEM;

EID: 84877837920     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-013-0338-3     Document Type: Article

References (36)

1. Reisin E, Jack AV. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med Clin North Am. 2009;93:733-51.
2. Owen J, Reisin E. Non-communicable disease: a welcome and long needed addition to the WHO's 2012 World Health Statistics. Curr Hypertens Rep. 2012;14:475-7.
3. Zhao M, Li Y, Wang J, Ebihara K, et al. Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats. Diabetes Obes Metab. 2011;13:1123-9.
4. Jenkins NT, Padilla J, Arce-Esquivel AA, et al. Effects of endurance exercise training, metformin, and their combination on adipose tissue leptin and IL-10 secretion in OLETF rats. J Appl Physiol. 2012;113:1873-83.
5. Chen B, Moore A, Escobedo LV, et al. Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats. Exp Biol Med (Maywood). 2011;236:309-14.
6. Siwy J, Zoja C, Klein J, et al. Evaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profiles. PLoS One. 2012;7:e51334. doi: 10.1371/journal.pone.0051334. Epub 2012 Dec 7.
7. Perfield 2nd JW, Ortinau LC, Pickering RT, et al. Altered hepatic lipid metabolism contributes to nonalcoholic Fatty liver disease in leptin-deficient ob/ob mice. J Obes. 2013;2013:296537. doi: 10.1155/2013/296537. Epub 2013 Jan 16.
8. Fellmann L, Nascimento AR, Tibiriça E, Bousquet P. Murine models for pharmacological studies of the metabolic syndrome. Pharmacol Ther. 2012. doi: 10.1016/j.pharmthera.2012.11.004. Epub ahead of print.
9. Rahmouni K. Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Curr Hypertens Rev. 2010;6:104-209.
10. Ketonen J, Shi J, Martonen E, Mervaala E. Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. Circ J. 2010;74:1479-87.
11. • Hilzendeger AM, Morgan DA, Brooks L, et al. A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity. Am J Physiol Heart Circ Physiol. 2012;303:H197-206. Intracerebroventricular losartan inhibited renal and brown adipose tissue (BAT), captopril attenuated leptin effect on renal and BAT SNA, while intracerebrovascular leptin in rats induced upregulation of brain RAS. All these indicate a brain leptin-RAS interaction.
12. • do Carmo JM, da Silva AA, Rushing JS, Hall JE. Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2012;302:R561-7. A functioning melanocortin system is critical in mediating the ability of leptin to induce hypertension, and its activation can lead to an increase in blood pressure in the absence of leptin.
13. Hall JE, da Silva AA. do Carmo JM, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010;285:17271-6.
14. Marc Y, Llorens-Cortes C. The role of the brain renin-angiotensin system in hypertension: implications for new treatment. Prog Neurobiol. 2011;95:89-103.
15. Grobe JL, Grobe CL, Beltz TG, et al. The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab. 2010;12:431-42.
16. Goncalves AC, Tank J, Diedrich A, et al. Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction. Hypertension. 2009;53:387-92.
17. Dubinion JH, da Silva AA, Hall JE. Chronic blood pressure and appetite responses to central leptin infusion in rats fed a high fat diet. J Hypertens. 2011;29:758-62.
18. da Silva AA, Carmo JM, Hall JE. Role of leptin and central nervous system melanocortins in obesity hypertension. Curr Opin Nephrol Hypertens. 2013;22:135-40.
19. Segal-Lieberman G, Bradley RL, Kokkotou E, et al. Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci USA. 2003;100:10085-90.
20. Pissios P. Animals models of MCH function and what they can tell us about its role in energy balance. Peptides. 2009;30:2040-4.
21. Xiong XQ, Chen WW, Han Y, et al. Enhanced adipose afferent reflex contributes to sympathetic activation in diet-induced obesity hypertension. Hypertension. 2012;60:1280-6.
22. Li P, Cui BP, Zhang LL, et al. Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure. Exp Physiol. 2013;98:435-43.
23. do Carmo JM, da Silva AA, Cai Z, et al. Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension. 2011;57:918-26.
24. Kievit P, Halem H, Marks DL. Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes. 2013;62:490-7.
25. Li W, Peng H, Seth DM, Feng Y. The prorenin and (pro)renin receptor: new players in the brain renin-angiotensin system? Int J Hypertens. 2012;2012:290635.
26. Sigmund CD. Divergent mechanism regulating fluid intake and metabolism by the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2012;302:R313-20.
27. Yiannikouris F, Karounos M, Charnigo R, et al. Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am J Physiol Regul Integr Comp Physiol. 2012;302:R244-51.
28. • Briones AM, Nguyen Dinh Cat A, Callera GE, et al. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension. 2012;59:1069-78. Functional adipocyte-derived aldosterone regulates adipocyte differentiation and vascular function in an autocrine and paracrine manner, respectively. These novel findings identify adipocytes (obtained from obese diabetic db/db) as a putative link between aldosterone and vascular dysfunction in diabetes mellitus-associated obesity.
29. • Nguyen Dinh Cat A, Briones AM, Callera GE, et al. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors. Hypertension. 2011;58:479-88. Adipocyte-derived factor regulates vsmc function through MAPK, indicating crosstalk between adipocytes and smooth muscle cells.
30. Yamashiro T, Kuge H, Zhang J, Honke K. Calcineurin mediates the angiotensin II-induced aldosterone synthesis in the adrenal glands by up-regulation of transcription of the CYP11B2 gene. J Biochem. 2010;148:115-23.
31. • Yiannikouris F, Gupte M, Putnam K, et al. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension. 2012;60:1524-30. Results suggest that adipose tissue serves as a major source of angiotensin II in the development of hypertension.
32. Northcott CA, Fink GD, Garver H, et al. The development of hypertension and hyperaldosteronism in a rodent model of life-long obesity. Endocrinology. 2012;153:1764-73.
33. Deji N, Kume S, Araki S, et al. Role of angiotensin II-mediated AMPK inactivation on obesity-related salt-sensitive hypertension. Biochem Biophys Res Commun. 2012;418:559-64.
34. Thatcher S, Yannikouris F, Gupte M, Cassis L. The adipose renin-angiotensin system: role in cardiovascular disease. Mol Cell Endocrinol. 2009;302:111-7.
35. Yasue S, Masuzaki H, Okada S, et al. Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens. 2010;23:425-31.
36. O'Seaghdha CM, Hwang SJ, Vasan RS, et al. Correlation of renin angiotensin and aldosterone system activity with subcutaneous and visceral adiposity: the Framingham heart study. BMC Endocr Disord. 2012;12:3.